General Information
edit

Website	stentys.com
Category	BioTech
Phone	+33 1 44 53 99 42
Email
Employees	5
Founded	2006
Description	coronary artery treatment developer

Offices
edit

Stentys S.A.S.

25, rue de Choiseul
Paris, 75002 , FRA

Stentys, Inc.

103 Carnegie Center
Princeton,
NJ, NJ 08540, USA

Chief Medical Officer

Chief Executive Officer

Chief Technology Officer

Director Regulatory Affairs

Total	$40.2M
Series A, 3/08 Scottish Equity Partners	$18M
Series B, 7/09 Sofinnova Ventures Credit Agricole Private Equity Scottish Equity Partners	$22.2M

Cornary artery bifurcation stenosis treatment developer

Stentys received $22.2M in Series B funding. (7/13/09)

Posted 7/13/09 at 1:09pm
Stentys received $18M in Series A funding. (3/19/08)

Posted 3/16/09 at 7:08am
Stentys added Hikmat Hojeibane as Chief Technology Officer .

Posted 3/16/09 at 7:08am
Stentys added Gonzague Issenmann as Chief Executive Officer .

Posted 3/16/09 at 7:08am
Stentys added René Spaargaren as Chief Medical Officer .

Posted 3/16/09 at 7:08am
Stentys added Luc Morisset as Director Regulatory Affairs .

Posted 3/16/09 at 7:08am